Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 94

1.

The Tumor Microenvironment of High Grade Serous Ovarian Cancer.

Stack MS, Nephew KP, Burdette JE, K Mitra A.

Cancers (Basel). 2018 Dec 26;11(1). pii: E21. doi: 10.3390/cancers11010021.

2.

Modeling the effect of ascites-induced compression on ovarian cancer multicellular aggregates.

Klymenko Y, Wates RB, Weiss-Bilka H, Lombard R, Liu Y, Campbell L, Kim O, Wagner D, Ravosa MJ, Stack MS.

Dis Model Mech. 2018 Sep 25;11(9). pii: dmm034199. doi: 10.1242/dmm.034199.

3.

With Great Age Comes Great Metastatic Ability: Ovarian Cancer and the Appeal of the Aging Peritoneal Microenvironment.

Harper EI, Sheedy EF, Stack MS.

Cancers (Basel). 2018 Jul 10;10(7). pii: E230. doi: 10.3390/cancers10070230. Review.

4.

Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer.

Drakes ML, Mehrotra S, Aldulescu M, Potkul RK, Liu Y, Grisoli A, Joyce C, O'Brien TE, Stack MS, Stiff PJ.

J Ovarian Res. 2018 May 30;11(1):43. doi: 10.1186/s13048-018-0414-z.

5.

Epigenetic Targeting of Adipocytes Inhibits High-Grade Serous Ovarian Cancer Cell Migration and Invasion.

Tang J, Pulliam N, Özeş A, Buechlein A, Ding N, Keer H, Rusch D, O'Hagan H, Stack MS, Nephew KP.

Mol Cancer Res. 2018 Aug;16(8):1226-1240. doi: 10.1158/1541-7786.MCR-17-0406. Epub 2018 May 14.

PMID:
29759990
6.

Aging Increases Susceptibility to Ovarian Cancer Metastasis in Murine Allograft Models and Alters Immune Composition of Peritoneal Adipose Tissue.

Loughran EA, Leonard AK, Hilliard TS, Phan RC, Yemc MG, Harper E, Sheedy E, Klymenko Y, Asem M, Liu Y, Yang J, Johnson J, Tarwater L, Shi Z, Leevy M, Ravosa MJ, Stack MS.

Neoplasia. 2018 Jun;20(6):621-631. doi: 10.1016/j.neo.2018.03.007. Epub 2018 May 10.

7.

RNA-seq Reveals the Overexpression of IGSF9 in Endometrial Cancer.

Shi Z, Li C, Tarwater L, Li J, Li Y, Kaliney W, Chandrashekar DS, Stack MS.

J Oncol. 2018 Feb 14;2018:2439527. doi: 10.1155/2018/2439527. eCollection 2018.

8.

Methods for the visualization and analysis of extracellular matrix protein structure and degradation.

Leonard AK, Loughran EA, Klymenko Y, Liu Y, Kim O, Asem M, McAbee K, Ravosa MJ, Stack MS.

Methods Cell Biol. 2018;143:79-95. doi: 10.1016/bs.mcb.2017.08.005.

9.

Quantitative proteomic analysis of murine white adipose tissue for peritoneal cancer metastasis.

Feist PE, Loughran EA, Stack MS, Hummon AB.

Anal Bioanal Chem. 2018 Feb;410(5):1583-1594. doi: 10.1007/s00216-017-0813-9. Epub 2017 Dec 27.

10.

Chemical Analysis of Morphological Changes in Lysophosphatidic Acid-Treated Ovarian Cancer Cells.

Bailey KA, Klymenko Y, Feist PE, Hummon AB, Stack MS, Schultz ZD.

Sci Rep. 2017 Nov 10;7(1):15295. doi: 10.1038/s41598-017-15547-7.

11.

Multiparity activates interferon pathways in peritoneal adipose tissue and decreases susceptibility to ovarian cancer metastasis in a murine allograft model.

Loughran EA, Phan RC, Leonard AK, Tarwater L, Asem M, Liu Y, Yang J, Klymenko Y, Johnson J, Shi Z, Hilliard TS, Blumenthaler M, Leevy M, Ravosa MJ, Stack MS.

Cancer Lett. 2017 Dec 28;411:74-81. doi: 10.1016/j.canlet.2017.09.028. Epub 2017 Sep 28.

12.

Assessment of common somatic mutations of EGFR, KRAS, BRAF, NRAS in pulmonary non-small cell carcinoma using iPLEX® HS, a new highly sensitive assay for the MassARRAY® System.

Sutton BC, Birse RT, Maggert K, Ray T, Hobbs J, Ezenekwe A, Kazmierczak J, Mosko M, Kish J, Bullock A, Shi Z, Stack MS, Irwin D.

PLoS One. 2017 Sep 19;12(9):e0183715. doi: 10.1371/journal.pone.0183715. eCollection 2017.

13.

Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya.

Sawe RT, Mining SK, Ofulla AV, Patel K, Guyah B, Chumba D, Prosperi JR, Kerper M, Shi Z, Sandoval-Cooper M, Taylor K, Badve S, Stack MS, Littlepage LE.

Trop Med Health. 2017 Aug 4;45:19. doi: 10.1186/s41182-017-0059-4. eCollection 2017.

14.

Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer.

Klymenko Y, Kim O, Stack MS.

Cancers (Basel). 2017 Aug 9;9(8). pii: E104. doi: 10.3390/cancers9080104. Review.

15.

Post-translational modification of the membrane type 1 matrix metalloproteinase (MT1-MMP) cytoplasmic tail impacts ovarian cancer multicellular aggregate dynamics.

Yang J, Kasberg WC, Celo A, Liang Z, Quispe K, Stack MS.

J Biol Chem. 2017 Aug 11;292(32):13111-13121. doi: 10.1074/jbc.M117.800904. Epub 2017 Jun 27.

16.

Heterogeneous Cadherin Expression and Multicellular Aggregate Dynamics in Ovarian Cancer Dissemination.

Klymenko Y, Johnson J, Bos B, Lombard R, Campbell L, Loughran E, Stack MS.

Neoplasia. 2017 Jul;19(7):549-563. doi: 10.1016/j.neo.2017.04.002. Epub 2017 Jun 9.

17.

Current Technologies and Recent Developments for Screening of HPV-Associated Cervical and Oropharyngeal Cancers.

Shah SS, Senapati S, Klacsmann F, Miller DL, Johnson JJ, Chang HC, Stack MS.

Cancers (Basel). 2016 Sep 9;8(9). pii: E85. doi: 10.3390/cancers8090085. Review.

18.

Wnt5a Signaling in Cancer.

Asem MS, Buechler S, Wates RB, Miller DL, Stack MS.

Cancers (Basel). 2016 Aug 26;8(9). pii: E79. doi: 10.3390/cancers8090079. Review.

19.

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis.

Lewellen KA, Metzinger MN, Liu Y, Stack MS.

J Vis Exp. 2016 Jul 18;(113). doi: 10.3791/53316.

PMID:
27500635
20.

Aggressive breast cancer in western Kenya has early onset, high proliferation, and immune cell infiltration.

Sawe RT, Kerper M, Badve S, Li J, Sandoval-Cooper M, Xie J, Shi Z, Patel K, Chumba D, Ofulla A, Prosperi J, Taylor K, Stack MS, Mining S, Littlepage LE.

BMC Cancer. 2016 Mar 10;16:204. doi: 10.1186/s12885-016-2204-6.

Supplemental Content

Loading ...
Support Center